| Value | ₹2,050 Cr |
|---|
BSE filing, NSE: CERA. Summary written from the filing by ALFA Finder's alert engine.
Cera Sanitaryware Ltd: key numbers
- Share price
- ₹4,439.00
- Market cap
- ₹5,725 Cr
- Revenue (annual)
- ₹2,050 Cr
- Net profit (annual)
- ₹204.2 Cr
- P/E (TTM)
- 28.2×Sector 41.2×
- Promoter holding
- 54.41%+0.00% QoQ
- FII holding
- 15.55%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Cera Sanitaryware Ltd
All →Cera Sanitaryware Board Meeting Date
Cera Sanitaryware scheduled a board meeting on 4 Nov 2026 to approve Q2/H1 results and re-appoint its CMD and an Independent Director. No financial figures or transaction values are disclosed in this intimation.
Cera Sanitaryware Other Announcement
Cera Sanitaryware filed a routine Regulation 74(5) certificate confirming the processing and listing of dematerialized shares for the quarter ended September 30, 2026.
Cera Sanitaryware Employee Stock Options
Cera Sanitaryware Employees Welfare Trust acquired 2,150 equity shares via market purchase. The transaction, valued at ₹1.21 Crore, increased the trust's holding to 0.05%.
- Value
- ₹1.21 Cr
Cera Sanitaryware Capital Structure Change
Cera Sanitaryware Employees Welfare Trust purchased 2,335 equity shares via market route for a total consideration of ₹1.30 Crore.
- Value
- ₹1.30 Cr
Cera Sanitaryware Credit Rating
Cera Sanitaryware Limited received reaffirmed credit ratings from CARE Ratings Limited for its bank facilities. The total facility amount under the rating action is ₹100 Crore.
- Value
- ₹100.0 Cr
Cera Sanitaryware Earnings Call Transcript: Key Takeaways
Cera Sanitaryware reports robust 19.5% revenue growth in Q1FY27, but EBITDA margins were severely dented by brass and gas cost spikes alongside one-time worker settlement provisions.
- Call
- Guides 19% growth
Other results update announcements
All →Aatmaj Healthcare Results Update
Aatmaj Healthcare reported H1 FY27 revenue of Rs. 16.96 crore and EBITDA of Rs. 2.04 crore. The company targets 80% revenue growth for FY27.
RPG Life Sciences Results Update
RPG Life Sciences reported Q2 FY27 revenue of ₹211.6 crore, growing 16.5%, and adjusted EBITDA of ₹50.1 crore. The API business integration continues to progress.
Praruh Technologies Results Update
Praruh Technologies reported strong H1 FY27 growth, with revenue rising 378% YoY to ₹84.06 Crore and PAT increasing 733% to ₹8.18 Crore.
CARE Ratings Results Update
CARE Ratings reported strong Q2 and H1 FY27 operating income and profit growth. The board also declared an interim dividend of Rs 10 per share.
EPACK Durables Results Update
EPACK Durable reported record first-half revenue and strong Q2 FY27 growth. The board also approved exiting its EPAVO joint venture stake.
3i Infotech Results Update
3i Infotech reported Q2FY27 revenue of Rs.182.0 crore, up 4.1% year-on-year. Quarterly PAT stood at Rs.6.7 crore and 25 new client wins were added.